Latest Period
Q4 2025
Security Snapshot
Outset Medical, Inc. - Common Stock, par value of $0.001 per share (OM) Institutional Ownership
CUSIP: 690145206
13F Institutional Holders and Ownership History from Q1 2025 to Q1 2026
Institutions Reporting
93
Shares (Excl. Options)
15,349,498
Price
$3.71
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, par value of $0.001 per share
- Symbol
- OM on Nasdaq
- Shares outstanding
- 18,116,200
- Price per share
- $4.08
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 15,349,498
- Total reported value
- $56,943,759
- % of total 13F portfolios
- 0%
- Share change
- -2,751,140
- Value change
- -$38,452,775
- Number of holders
- 93
- Price from insider filings
- $4.08
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- OM - Outset Medical, Inc. - Common Stock, par value of $0.001 per share is tracked under CUSIP 690145206.
- 93 institutions reported positions in Q4 2025.
- 8 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 93 to 36 between Q4 2025 and Q1 2026.
- Reported value moved from $56,943,759 to $16,252,910.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 93 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 690145206?
CUSIP 690145206 identifies OM - Outset Medical, Inc. - Common Stock, par value of $0.001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 690145206:
Significant Owners of Outset Medical, Inc. - Common Stock, par value of $0.001 per share (OM) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 14% | $30,149,556 | 2,596,861 | FMR LLC | 31 Mar 2025 | |||
| BML Investment Partners, L.P. | 10% | +12% | $9,739,269 | +$1,005,184 | 1,902,201 | +12% | BML Investment Partners, L.P. | 12 Feb 2026 |
| Woodline Partners LP | 7.5% | $15,392,352 | 1,325,784 | Woodline Partners LP | 31 Mar 2025 | |||
| BlackRock, Inc. | 6.8% | +22% | $17,135,284 | +$3,284,072 | 1,213,547 | +24% | BlackRock, Inc. | 30 Sep 2025 |
| PERCEPTIVE ADVISORS LLC | 6.7% | $14,028,758 | 1,208,334 | Perceptive Advisors LLC | 31 Mar 2025 | |||
| VANGUARD GROUP INC | 5.6% | $18,919,737 | 991,429 | The Vanguard Group | 30 Jun 2025 | |||
| BANK OF AMERICA CORP /DE/ | 5.2% | $4,866,857 | 950,558 | BANK OF AMERICA CORP /DE/ | 31 Dec 2025 | |||
| T. Rowe Price Investment Management, Inc. | 0% | -99% | $33,874 | -$22,601,277 | 2,399 | -100% | T. Rowe Price Investment Management, Inc. | 30 Sep 2025 |
As of 31 Dec 2025, 93 institutional investors reported holding 15,349,498 shares of Outset Medical, Inc. - Common Stock, par value of $0.001 per share (OM). This represents 85% of the company’s total 18,116,200 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Outset Medical, Inc. - Common Stock, par value of $0.001 per share (OM) together control 78% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 15% | 2,640,802 | -0.9% | 0% | $9,797,376 |
| Alyeska Investment Group, L.P. | 8.9% | 1,614,582 | 0% | 0.02% | $5,990,099 |
| Woodline Partners LP | 7.3% | 1,325,855 | 0% | 0.02% | $4,918,922 |
| BlackRock, Inc. | 7.1% | 1,289,318 | +3.2% | 0% | $4,783,370 |
| VANGUARD GROUP INC | 5.4% | 977,969 | -0.47% | 0% | $3,628,265 |
| BANK OF AMERICA CORP /DE/ | 5.2% | 950,544 | +4024% | 0% | $3,526,518 |
| PERCEPTIVE ADVISORS LLC | 4.6% | 833,333 | 0% | 0.06% | $3,091,665 |
| Ensign Peak Advisors, Inc | 3.1% | 560,169 | +72% | 0% | $2,078,227 |
| BML Capital Management, LLC | 3% | 543,180 | 0% | 1.8% | $2,015,198 |
| PFM Health Sciences, LP | 2.9% | 530,796 | -69% | 0.2% | $1,969,253 |
| Assenagon Asset Management S.A. | 2.8% | 508,414 | +35% | 0% | $1,886,216 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 400,363 | +0.78% | 0% | $1,485,685 |
| STATE STREET CORP | 1.8% | 330,134 | -0.48% | 0% | $1,224,797 |
| NORTHERN TRUST CORP | 1.3% | 232,587 | -1.8% | 0% | $862,898 |
| AQR CAPITAL MANAGEMENT LLC | 1% | 180,363 | +248% | 0% | $669,146 |
| DEUTSCHE BANK AG\ | 0.98% | 177,681 | +158% | 0% | $659,197 |
| MARSHALL WACE, LLP | 0.94% | 170,758 | -59% | 0% | $633,512 |
| DIMENSIONAL FUND ADVISORS LP | 0.87% | 158,352 | +372% | 0% | $587,372 |
| MORGAN STANLEY | 0.77% | 139,719 | -68% | 0% | $518,358 |
| ACADIAN ASSET MANAGEMENT LLC | 0.7% | 127,268 | +27% | 0% | $468,000 |
| Catalio Capital Management, LP | 0.65% | 118,279 | 0% | 0.08% | $438,815 |
| JPMORGAN CHASE & CO | 0.6% | 109,376 | -6% | 0% | $405,785 |
| XTX Topco Ltd | 0.56% | 100,612 | +877% | 0.01% | $373,271 |
| STIFEL FINANCIAL CORP | 0.44% | 79,924 | 0% | $296,516 | |
| UBS Group AG | 0.4% | 73,160 | +0.99% | 0% | $271,424 |
Institutional Holders of Outset Medical, Inc. - Common Stock, par value of $0.001 per share (OM) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 4,232,604 | $16,252,910 | +$5,877,099 | $3.84 | 36 |
| 2025 Q4 | 15,349,498 | $56,943,759 | -$38,452,775 | $3.71 | 93 |
| 2025 Q3 | 17,649,176 | $249,202,204 | -$11,456,191 | $14.12 | 96 |
| 2025 Q2 | 18,242,288 | $350,434,222 | +$69,197,262 | $19.21 | 91 |
| 2025 Q1 | 14,676,599 | $162,319,841 | +$162,319,498 | $11.06 | 59 |